ENDOMETRIAL NEOPLASMS
Clinical trials for ENDOMETRIAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL NEOPLASMS trials appear
Sign up with your email to follow new studies for ENDOMETRIAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo challenges chemotherapy for Tough-to-Treat uterine cancer
Disease control CompletedThis large, completed study compared a new two-drug combination (pembrolizumab and lenvatinib) against standard chemotherapy for women with advanced or returning endometrial cancer. The goal was to see if the combination could better control the cancer's growth and help patients …
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New tool aims to protect cancer Survivors' hearts
Disease control CompletedThis study tested a computer tool that automatically shows a cancer survivor's heart health risks using their existing medical records. The goal was to see if this tool helped survivors and their cancer doctors have better conversations about heart health, leading to more referra…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug duo challenges chemo for Tough-to-Treat uterine cancer
Disease control CompletedThis study tested whether a combination of two newer drugs (pembrolizumab and lenvatinib) works better than standard chemotherapy for women with advanced or recurrent endometrial (uterine) cancer. It involved 130 participants and directly compared how long patients lived without …
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New combo therapy shows promise against Tough-to-Treat uterine cancer
Disease control CompletedThis large, completed Phase 3 trial tested whether a new combination of two drugs (lenvatinib and pembrolizumab) worked better than standard chemotherapy for women with advanced endometrial cancer that had worsened after initial treatment. The main goal was to see if the combinat…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New surgical glow technique aims for more precise cancer mapping
Diagnosis CompletedThis study compared two ways to find the first lymph nodes that cancer might spread to during surgery for early-stage endometrial cancer. Researchers tested a new method where surgeons keep injecting a safe green dye until they can see the tiny drainage channels in real-time. The…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: NA • Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital • Aim: Diagnosis
Last updated Apr 03, 2026 14:42 UTC